Key Events This Week
Jul 20: Stock surged 2.38% to Rs.339.85, outperforming Sensex
Jul 21: MarketsMOJO downgraded Wanbury Ltd to Hold citing valuation concerns
Jul 22: Valuation grade shifted from attractive to fair amid sector comparison
Jul 24: Week ended with a modest gain of 0.80% at Rs.332.50 despite Sensex decline

Wanbury Ltd Downgraded to Hold Amid Valuation Concerns Despite Strong Financials
2026-07-22 08:26:49Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 21 July 2026. This revision reflects a shift in valuation metrics alongside a nuanced assessment of the company’s financial trends, quality parameters, and technical outlook. Despite robust operational performance and impressive long-term returns, concerns over valuation and debt levels have tempered enthusiasm among investors.
Read full news article
Wanbury Ltd Valuation Shifts to Fair Amid Strong Returns and Sector Comparison
2026-07-22 08:01:38Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid strong operational metrics and a competitive peer landscape, prompting investors to reassess the stock’s price attractiveness relative to historical and sector benchmarks.
Read full news articleBoard Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
03-Aug-2026 | Source : BSEWanbury Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of the Board of Directors of Wanbury Limited is scheduled to be held on Tuesday August 11 2026 inter-alia to consider and approve the Un-audited Financial Results for the first quarter and three months ended June 30 2026.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
30-Jul-2026 | Source : BSEPress Release - No DMF deficiency letter received from the office of USFDA for multiple ANDAs
Intimation Of Completion Of Inspection By The United States Food And Drug Administration (USFDA) At The Companys Facility At Tanuku West Godavari District Andhra Pradesh
22-Jul-2026 | Source : BSEIntimation of completion of inspection by the United States Food and Drug Administration (USFDA) at the Companys Facilty.
Corporate Actions
11 Aug 2026
Wanbury Ltd has declared 10% dividend, ex-date: 29 Jul 10
No Splits history available
No Bonus history available
No Rights history available










